Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Diagnostic Testing For STDs Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Diagnostic Testing For STDs Market Status and Forecast (2016-2027)
      • 1.3.2 Global Diagnostic Testing For STDs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Diagnostic Testing For STDs Supply by Company

    • 2.1 Global Diagnostic Testing For STDs Sales Value by Company
    • 2.2 Diagnostic Testing For STDs Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Diagnostic Testing For STDs Market Status by Category

    • 3.1 Diagnostic Testing For STDs Category Introduction
      • 3.1.1 Syphilis Testing
      • 3.1.2 Gonorrhea Testing
      • 3.1.3 Chlamydia Testing
      • 3.1.4 Herpes Simplex Virus Testing
      • 3.1.5 Human Immunodeficiency Virus Testing
      • 3.1.6 Human Papilloma Virus Testing
      • 3.1.7 Others
    • 3.2 Global Diagnostic Testing For STDs Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Diagnostic Testing For STDs Market Status by End User/Segment

    • 4.1 Diagnostic Testing For STDs Segment by End User/Segment
      • 4.1.1 Laboratory Testing
      • 4.1.2 Point Of Care Testing
    • 4.2 Global Diagnostic Testing For STDs Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Diagnostic Testing For STDs Market Status by Region

    • 5.1 Global Diagnostic Testing For STDs Market by Region
    • 5.2 North America Diagnostic Testing For STDs Market Status
    • 5.3 Europe Diagnostic Testing For STDs Market Status
    • 5.4 Asia Pacific Diagnostic Testing For STDs Market Status
    • 5.5 Central & South America Diagnostic Testing For STDs Market Status
    • 5.6 Middle East & Africa Diagnostic Testing For STDs Market Status

    6 North America Diagnostic Testing For STDs Market Status

    • 6.1 North America Diagnostic Testing For STDs Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Diagnostic Testing For STDs Market Status

    • 7.1 Europe Diagnostic Testing For STDs Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Diagnostic Testing For STDs Market Status

    • 8.1 Asia Pacific Diagnostic Testing For STDs Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Diagnostic Testing For STDs Market Status

    • 9.1 Central & South America Diagnostic Testing For STDs Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Diagnostic Testing For STDs Market Status

    • 10.1 Middle East & Africa Diagnostic Testing For STDs Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Diagnostic Testing For STDs Market Forecast by Category and by End User/Segment

    • 12.1 Global Diagnostic Testing For STDs Sales Value Forecast (2022-2027)
    • 12.2 Global Diagnostic Testing For STDs Forecast by Category
    • 12.3 Global Diagnostic Testing For STDs Forecast by End User/Segment

    13 Global Diagnostic Testing For STDs Market Forecast by Region/Country

    • 13.1 Global Diagnostic Testing For STDs Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Siemens Healthcare AG
      • 14.1.1 Company Information
      • 14.1.2 Diagnostic Testing For STDs Product Introduction
      • 14.1.3 Siemens Healthcare AG Diagnostic Testing For STDs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Qiagen, Inc.
      • 14.2.1 Company Information
      • 14.2.2 Diagnostic Testing For STDs Product Introduction
      • 14.2.3 Qiagen, Inc. Diagnostic Testing For STDs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 MedMira, Inc.
      • 14.3.1 Company Information
      • 14.3.2 Diagnostic Testing For STDs Product Introduction
      • 14.3.3 MedMira, Inc. Diagnostic Testing For STDs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Hologic, Inc.
      • 14.4.1 Company Information
      • 14.4.2 Diagnostic Testing For STDs Product Introduction
      • 14.4.3 Hologic, Inc. Diagnostic Testing For STDs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 F.Hoffman La-Roche Ltd.
      • 14.5.1 Company Information
      • 14.5.2 Diagnostic Testing For STDs Product Introduction
      • 14.5.3 F.Hoffman La-Roche Ltd. Diagnostic Testing For STDs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Diasorin S.p.A
      • 14.6.1 Company Information
      • 14.6.2 Diagnostic Testing For STDs Product Introduction
      • 14.6.3 Diasorin S.p.A Diagnostic Testing For STDs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Danaher Corporation
      • 14.7.1 Company Information
      • 14.7.2 Diagnostic Testing For STDs Product Introduction
      • 14.7.3 Danaher Corporation Diagnostic Testing For STDs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Bio-Rad Laboratories, Inc.
      • 14.8.1 Company Information
      • 14.8.2 Diagnostic Testing For STDs Product Introduction
      • 14.8.3 Bio-Rad Laboratories, Inc. Diagnostic Testing For STDs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Abbott Laboratories, Inc.
      • 14.9.1 Company Information
      • 14.9.2 Diagnostic Testing For STDs Product Introduction
      • 14.9.3 Abbott Laboratories, Inc. Diagnostic Testing For STDs Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Diagnostic Testing For STDs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Diagnostic Testing For STDs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Syphilis Testing
      Gonorrhea Testing
      Chlamydia Testing
      Herpes Simplex Virus Testing
      Human Immunodeficiency Virus Testing
      Human Papilloma Virus Testing
      Others

      Segmented by End User/Segment
      Laboratory Testing
      Point Of Care Testing

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Siemens Healthcare AG
      Qiagen, Inc.
      MedMira, Inc.
      Hologic, Inc.
      F.Hoffman La-Roche Ltd.
      Diasorin S.p.A
      Danaher Corporation
      Bio-Rad Laboratories, Inc.
      Abbott Laboratories, Inc.
      Buy now